Key result
Insulin-sensitizing agents, particularly metformin, are reviewed for their role in improving insulin sensitivity and managing infertility in women with polycystic ovary syndrome.
Why the study?
Does the use of insulin-sensitizing agents improve outcomes in women with polycystic ovary syndrome?
Population
Women with polycystic ovary syndrome (PCOS) and insulin resistance
Design
Review
Authors
Loading...
May support metformin in PCOS infertility; leaves open confirmation by rigorous RCTs.
Does the use of insulin-sensitizing agents improve outcomes in women with polycystic ovary syndrome?
Insulin-sensitizing agents like metformin are discussed as a therapeutic strategy for managing infertility and metabolic risks in women with PCOS.
Checa et al. (2005) conducted a review in Polycystic ovary syndrome (PCOS) and insulin resistance. Insulin-sensitizing agents (metformin) was evaluated. Insulin-sensitizing agents, particularly metformin, are reviewed for their role in improving insulin sensitivity and managing infertility in women with polycystic ovary syndrome.
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: